Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309196680> ?p ?o ?g. }
- W4309196680 endingPage "106553" @default.
- W4309196680 startingPage "106553" @default.
- W4309196680 abstract "Cancer progression results from activation of various signaling networks. Among these, PI3K/Akt signaling contributes to proliferation, invasion, and inhibition of apoptosis. Hepatocellular carcinoma (HCC) is a primary liver cancer with high incidence rate, especially in regions with high prevalence of viral hepatitis infection. Autoimmune disorders, diabetes mellitus, obesity, alcohol consumption, and inflammation can also lead to initiation and development of HCC. The treatment of HCC depends on the identification of oncogenic factors that lead tumor cells to develop resistance to therapy. The present review article focuses on the role of PI3K/Akt signaling in HCC progression. Activation of PI3K/Akt signaling promotes glucose uptake, favors glycolysis and increases tumor cell proliferation. It inhibits both apoptosis and autophagy while promoting HCC cell survival. PI3K/Akt stimulates epithelial-to-mesenchymal transition (EMT) and increases matrix-metalloproteinase (MMP) expression during HCC metastasis. In addition to increasing colony formation capacity and facilitating the spread of tumor cells, PI3K/Akt signaling stimulates angiogenesis. Therefore, silencing PI3K/Akt signaling prevents aggressive HCC cell behavior. Activation of PI3K/Akt signaling can confer drug resistance, particularly to sorafenib, and decreases the radio-sensitivity of HCC cells. Anti-cancer agents, like phytochemicals and small molecules can suppress PI3K/Akt signaling by limiting HCC progression. Being upregulated in tumor tissues and clinical samples, PI3K/Akt can also be used as a biomarker to predict patients’ response to therapy." @default.
- W4309196680 created "2022-11-24" @default.
- W4309196680 creator A5002304555 @default.
- W4309196680 creator A5006714157 @default.
- W4309196680 creator A5013368102 @default.
- W4309196680 creator A5021477791 @default.
- W4309196680 creator A5025512796 @default.
- W4309196680 creator A5028415995 @default.
- W4309196680 creator A5031931379 @default.
- W4309196680 creator A5034304968 @default.
- W4309196680 creator A5043223850 @default.
- W4309196680 creator A5044842109 @default.
- W4309196680 creator A5060761825 @default.
- W4309196680 creator A5063128309 @default.
- W4309196680 creator A5068147512 @default.
- W4309196680 creator A5070231568 @default.
- W4309196680 creator A5078858622 @default.
- W4309196680 creator A5087709925 @default.
- W4309196680 creator A5088484454 @default.
- W4309196680 date "2023-01-01" @default.
- W4309196680 modified "2023-10-11" @default.
- W4309196680 title "Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges" @default.
- W4309196680 cites W1525058971 @default.
- W4309196680 cites W1557969557 @default.
- W4309196680 cites W1580931878 @default.
- W4309196680 cites W1785822877 @default.
- W4309196680 cites W1817869836 @default.
- W4309196680 cites W1895463703 @default.
- W4309196680 cites W1934027570 @default.
- W4309196680 cites W1964915114 @default.
- W4309196680 cites W1969248336 @default.
- W4309196680 cites W1971837077 @default.
- W4309196680 cites W1973171841 @default.
- W4309196680 cites W1976677664 @default.
- W4309196680 cites W1976792034 @default.
- W4309196680 cites W1981027541 @default.
- W4309196680 cites W1981406217 @default.
- W4309196680 cites W1982604280 @default.
- W4309196680 cites W1984404613 @default.
- W4309196680 cites W1984489015 @default.
- W4309196680 cites W1985125414 @default.
- W4309196680 cites W1997142937 @default.
- W4309196680 cites W1999840617 @default.
- W4309196680 cites W2001007571 @default.
- W4309196680 cites W2002196794 @default.
- W4309196680 cites W2002771508 @default.
- W4309196680 cites W2003661489 @default.
- W4309196680 cites W2005334224 @default.
- W4309196680 cites W2009685214 @default.
- W4309196680 cites W2009886463 @default.
- W4309196680 cites W2017666849 @default.
- W4309196680 cites W2018626410 @default.
- W4309196680 cites W2024611216 @default.
- W4309196680 cites W2026198465 @default.
- W4309196680 cites W2027509505 @default.
- W4309196680 cites W2028308239 @default.
- W4309196680 cites W2033608521 @default.
- W4309196680 cites W2033893737 @default.
- W4309196680 cites W2035390577 @default.
- W4309196680 cites W2051099402 @default.
- W4309196680 cites W2052853635 @default.
- W4309196680 cites W2055588308 @default.
- W4309196680 cites W2058729725 @default.
- W4309196680 cites W2059660194 @default.
- W4309196680 cites W2060776529 @default.
- W4309196680 cites W2061743943 @default.
- W4309196680 cites W2061917886 @default.
- W4309196680 cites W2062629138 @default.
- W4309196680 cites W2064641041 @default.
- W4309196680 cites W2069076782 @default.
- W4309196680 cites W2072061998 @default.
- W4309196680 cites W2074671217 @default.
- W4309196680 cites W2078474108 @default.
- W4309196680 cites W2081871084 @default.
- W4309196680 cites W2086556660 @default.
- W4309196680 cites W2087913996 @default.
- W4309196680 cites W2092667428 @default.
- W4309196680 cites W2094339002 @default.
- W4309196680 cites W2095910264 @default.
- W4309196680 cites W2097259163 @default.
- W4309196680 cites W2098735966 @default.
- W4309196680 cites W2104812730 @default.
- W4309196680 cites W2105148633 @default.
- W4309196680 cites W2105194463 @default.
- W4309196680 cites W2107542389 @default.
- W4309196680 cites W2110842318 @default.
- W4309196680 cites W2117327025 @default.
- W4309196680 cites W2128795228 @default.
- W4309196680 cites W2143052516 @default.
- W4309196680 cites W2145993791 @default.
- W4309196680 cites W2146032173 @default.
- W4309196680 cites W2146974078 @default.
- W4309196680 cites W2147895894 @default.
- W4309196680 cites W2149024868 @default.
- W4309196680 cites W2149729293 @default.
- W4309196680 cites W2154576017 @default.
- W4309196680 cites W2160378721 @default.
- W4309196680 cites W2166625995 @default.